Tyrosine Kinase Inhibitors: all 10,744 studies that test it
Page 97 of 108. Open to participants first (1,949), then studies with results posted, then the rest; newest registration first within each.
- Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma PatientsCompletedNCT00891475Phase 1/2
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)CompletedNCT00889382Phase 1/2
- Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal CancerTerminatedNCT00889343Phase 2
- Curcumin in Pediatric Inflammatory Bowel DiseaseCompletedNCT00889161Phase 1
- Sorafenib in Relapsed High Grade OsteosarcomaCompletedNCT00889057Phase 2
- Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal CancerTerminatedNCT00888810Phase 2
- Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid CarcinomaCompletedNCT00887107Phase 2
- A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsCompletedNCT00886132Phase 2
- Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic CancerCompletedNCT00885066Phase 1
- Trial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid TumorsCompletedNCT00884845Phase 1
- Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid TumorsCompletedNCT00884676Phase 1
- Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced AdenocarcinomaCompletedNCT00883480Not applicable
- XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00882869Phase 1/2
- Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryWithdrawnNCT00882765Phase 2
- Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid TumorsCompletedNCT00881166Phase 1
- Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic MelanomaCompletedNCT00881049Phase 2
- A Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 TabletsCompletedNCT00879346Phase 1
- GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by SurgeryActive, not recruitingNCT00878163Phase 1
- Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)CompletedNCT00875745Phase 1
- Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced CancerCompletedNCT00875264Phase 1
- Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by SurgeryCompletedNCT00874874Phase 2
- Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 MutationCompletedNCT00874419Phase 3
- Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer PatientsCompletedNCT00873353Phase 2
- Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by SurgeryTerminatedNCT00873002Phase 1
- Study of Dasatinib and Bendamustine in Chronic Lymphocytic LeukemiaWithdrawnNCT00872976Phase 1
- A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular CancerCompletedNCT00872014Phase 2
- Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00870532Phase 1
- A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid TumorsCompletedNCT00869895Phase 1
- External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00869570Phase 1/2
- A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid LeukemiaCompletedNCT00866736Phase 2
- Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung CancerCompletedNCT00866528Phase 1
- Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3CompletedNCT00866138Phase 2
- Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent GlioblastomaCompletedNCT00864864Early Phase 1
- Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of NeratinibCompletedNCT00864487Phase 1
- A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic CancerCompletedNCT00862524Phase 1/2
- To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.CompletedNCT00861419Phase 1
- VEG111485: A QTc Study of PazopanibCompletedNCT00861029Phase 1
- Study Evaluating The Potential Effect Of Multiple Doses Of Neratinib On The Pharmacokinetics Of A Single Dose Of DigoxinCompletedNCT00860223Phase 1
- Pharmacodynamic Study of Axitinib in Patients With Advanced Solid MalignanciesCompletedNCT00859118Phase 1
- First Line Hepato Cellular Carcinoma (HCC)CompletedNCT00858871Phase 3
- Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib TherapyCompletedNCT00858806Phase 2
- Phase I Study to Assess Absorption, Metabolism & Excretion of a Single Oral Dose [14C]AZD0530 in Healthy Male VolunteersCompletedNCT00853983Phase 1
- Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid LeukemiaCompletedNCT00852566Phase 2
- Docetaxel With or Without a Phytochemical in Treating Patients With Breast CancerTerminatedNCT00852332Phase 2
- Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal CancerCompletedNCT00851045Phase 2
- Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung CancerTerminatedNCT00850577Phase 2
- Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)CompletedNCT00850382Phase 1/2
- Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell LymphomaCompletedNCT00849654Phase 1
- A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast CancerCompletedNCT00849329Phase 1
- Study of Sorafenib in Patients With Advanced Renal Cell CarcinomaCompletedNCT00848640Phase 2
- Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular CarcinomaCompletedNCT00846131Phase 1
- Glivec in Pediatric Chronic Myeloid Leukemia (CML)CompletedNCT00845221Phase 4
- Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00844688Phase 2
- Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver TransplantCompletedNCT00844168Phase 1
- Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent AsthmaCompletedNCT00842270Phase 2
- Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line TreatmentCompletedNCT00840125Phase 2
- Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin TreatmentStatus unknownNCT00839111Phase 2
- 2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT00835471Phase 2
- A Study of ARRY-334543 and Docetaxel in Patients With Advanced CancerCompletedNCT00833326Phase 1
- Efficacy of AB1010 in Patients With Systemic Indolent MastocytosisCompletedNCT00831974Phase 2
- Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid ArthritisCompletedNCT00831922Phase 2
- A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung CancerTerminatedNCT00830245Phase 2
- A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic LeukemiaWithdrawnNCT00829647Phase 1/2
- Hepatic Impairment StudyCompletedNCT00829231Phase 1
- Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular CarcinomaTerminatedNCT00828594Phase 1
- Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)CompletedNCT00827138Phase 1
- An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00826878Phase 1
- Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib TreatmentCompletedNCT00825955Phase 3
- Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)TerminatedNCT00823290Phase 1
- Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant GliomasCompletedNCT00822887Phase 1
- Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue SarcomaCompletedNCT00822848Phase 1
- Vandetanib and Sirolimus in Patients With Recurrent GlioblastomaCompletedNCT00821080Phase 1
- A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer PatientsCompletedNCT00821054Phase 1
- Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor CellsTerminatedNCT00820924Phase 2
- Activity Study of Sunitinib In Metastatic Pretreated Urothelial CancerStatus unknownNCT00818350Phase 1/2
- Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00816283Phase 1
- Masitinib in Severe Indolent or Smoldering Systemic MastocytosisCompletedNCT00814073Phase 3
- Study Evaluating TwoTablet Formulations of Neratinib (HKI-272)CompletedNCT00814060Phase 1
- Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the BrainCompletedNCT00814021Phase 2
- Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to ChemotherapyCompletedNCT00813423Phase 1
- A Phase 1 Study of AMG 208 in Subjects With Advanced Solid TumorsCompletedNCT00813384Phase 1
- Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)TerminatedNCT00812240Phase 3
- A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNCT00811993Phase 1
- Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV MelanomaStatus unknownNCT00811759Phase 1/2
- Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast CancerCompletedNCT00811369Phase 2
- Hydroxychloroquine and Gefitinib to Treat Lung CancerStatus unknownNCT00809237Phase 1/2
- Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00809211Phase 2
- Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC)WithdrawnNCT00808145Phase 2
- Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain MetastasesTerminatedNCT00807170Phase 1
- Randomized Gefitinib TrialCompletedNCT00807066Phase 3
- FOLFIRI and Sunitinib in Metastatic Colorectal CancerCompletedNCT00806663Phase 2
- Study of ENMD-2076 in Patients With Multiple MyelomaCompletedNCT00806065Phase 1
- Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)CompletedNCT00802555Phase 1
- Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyStatus unknownNCT00801385Phase 2
- A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal CancerCompletedNCT00801294Phase 2
- Sorafenib in Previously Treated Malignant MesotheliomaStatus unknownNCT00794859Phase 2
- Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and DacarbazineCompletedNCT00794235Phase 2
- Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid TumorsCompletedNCT00793897Phase 1
- The Efficacy and Safety of Curcuma Domestica Extracts and Ibuprofen in Knee OsteoarthritisCompletedNCT00792818Phase 3